Core Viewpoint - Midland Exploration Inc. is advancing its gold and copper-gold exploration activities in Quebec for 2026, focusing on several projects in partnership with major companies, with a planned exploration budget exceeding $12 million [4][36]. Exploration Activities - Midland's exploration budget for 2026 is over $12 million, with $9.5 million from Midland and $2.5 million from partners, and nearly 15,000 meters of drilling planned [4]. - The company is collaborating with major partners such as BHP, Rio Tinto, Barrick Gold, and Agnico Eagle to advance multiple projects [4]. Project Highlights - **Jouvex Project**: Located 10 kilometers northwest of the Douay gold deposit, showing potential for volcanic massive sulfide-type mineralization based on historical drilling data and drone-supported magnetic surveys [6]. - **Casault Project**: In partnership with Wallbridge, this project has identified gold-in-till anomalies and new exploration targets along the Sunday Lake Deformation Zone, with a planned drilling campaign of 3,000 meters in 2026 [9][12]. - **La Peltrie Project**: A joint venture with Probe, this project has extended known Cu-Au-Ag-Mo mineralization and completed extensive soil sampling programs [13][14]. - **Caniapisc Au Project**: Located in the Ashuanipi Subprovince, this project confirmed historical gold anomalies and identified several mineralized boulders during exploration [22][23]. - **Lac Bernard and Viau Projects**: New projects identified based on regional studies, with lake bottom sediment sampling confirming several Cu and Au anomalies [25][26]. - **Willbob Project**: Acquired 100% interest in the Kan project, expanding exploration rights and identifying gold mineralization in altered iron formations [27][28]. - **Nachicapau Project**: A strategic alliance with SOQUEM has identified several Cu-Au-Ag mineralized zones, with ongoing exploration to determine the extent of mineralization [29][31]. - **Malaco Mountain Project**: This project has discovered Cu-Au-REE mineralization, with follow-up exploration planned for 2026 [32][33]. Strategic Partnerships - Midland emphasizes partnerships with reputable companies to enhance exploration efforts and generate shareholder value, indicating a preference for collaborative projects [36].

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026. ...

Core Viewpoint - Midland Exploration Inc. has initiated a 1,600-meter diamond drilling program on its Jouvex gold property, aiming to explore new gold potential in an area previously overlooked [3][4]. Group 1: Drilling Program Details - The diamond drilling program is set to begin in January 2026, consisting of five drill holes targeting magnetic anomalies and induced polarization (IP) anomalies [5]. - Historical drill hole JOU-1-84 showed promising alteration patterns, indicating favorable conditions for gold mineralization [5]. - The main target for the drilling is a strongly positive magnetic anomaly associated with a chargeability zone, which may suggest the presence of disseminated sulphides [5]. Group 2: Exploration Background - Exploration activities on the Jouvex property resumed in 2024-2025, including drone-supported magnetic surveys and an IP survey totaling 30 line kilometers [4]. - The southern part of the Jouvex property has been identified as the main area for current exploration efforts, with geological modifications indicating potential for VMS mineralization [6]. - The magnetic surveys suggest that major structures in the southern part of the project could be favorable sites for syenitic intrusions, similar to those found in the Douay area [6]. Group 3: Company Overview - Midland Exploration targets the mineral potential of Quebec, focusing on discovering new world-class deposits of gold and critical metals [7]. - The company collaborates with reputable partners, including Rio Tinto Exploration Canada Inc. and BHP Canada Inc., to enhance its exploration efforts [7]. - Midland is actively reviewing additional opportunities to expand its portfolio and generate shareholder value [9].

Core Insights - Midland Exploration Inc. has announced the results of its 2025 drilling campaign for lithium on the Galinée project, which is located near the Adina lithium deposit [7][19] - The drilling program included a total of 14 diamond drill holes and 9 reverse circulation drill holes, totaling 4,105.09 meters, with significant lithium and cesium mineralization identified [9][11] Drilling Results - The best lithium results from the 2025 drilling program include: - 1.14% Li2O over 30.59 meters, including 1.77% Li2O over 18.39 meters (hole TLIB0051) - 0.53% Li2O over 22.90 meters, including 1.09% Li2O over 6.10 meters (hole TLIB0044) - 1.08% Li2O over 17.10 meters (hole TLIB0034) [11][12] - New cesium mineralization was identified with results such as: - 9.15% Cs2O over 6.40 meters (hole TLIB0006) - 1.89% Cs2O over 12.10 meters (hole TLIB0044) [11][13] Geological Observations - The Galinée project exhibits two distinct styles of lithium mineralization: - The Iceberg area features a stacked spodumene pegmatite system that is 10 to 20 meters thick - South of Iceberg, the pegmatites are generally less than 10 meters thick and laterally extensive [15][16] - The Iceberg spodumene pegmatite bodies remain open along strike and to depth, indicating potential for further exploration [16] Project Background - The Galinée project is strategically located approximately 5 kilometers east of the Adina deposit, which has significant mineral resources [19] - Midland has a partnership with Rio Tinto Exploration Canada Inc. (RTEC) under an option agreement, with RTEC recently paying $487,500 as part of this agreement [20] Future Plans - Further drilling is planned to better define the geometry and extension of the lithium pegmatites identified in the current drilling campaign [16]

Core Insights - Pediatrix Medical Group, Inc. (MD) is positioned for growth due to increased collection activity, improved patient acuity, higher contract administrative fees, a favorable payor mix, and strategic acquisitions [1][10] - MD's shares have increased by 55.2% over the past six months, significantly outperforming the industry average of 6.7% [1][10] Company Overview - Pediatrix Medical has a market capitalization of $1.8 billion and offers various physician services in newborn, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties [2] - The company's forward P/E ratio is 10.35X, which is lower than the industry average of 17.93X, and it holds a Value Score of B [2] Earnings Estimates - The Zacks Consensus Estimate for MD's 2025 earnings is $2.07 per share, reflecting a year-over-year increase of 37.1% [3] - The revenue consensus for 2025 is projected at $1.9 billion, with MD having beaten earnings estimates in the past four quarters by an average surprise of 35.4% [3] Growth Drivers - MD is experiencing growth in same-unit revenues and pricing, supported by an improved payer mix, solid revenue cycle management (RCM) cash collections, increased patient acuity, and higher administrative fees from hospital contracts [4] - In Q3 2025, same-unit revenues from net reimbursement-related factors rose by 7.6% year-over-year [5] Financial Performance - MD has raised its adjusted EBITDA guidance for 2025 to a range of $270-$290 million, up from the previous range of $245 million to $255 million [5] - Total operating expenses decreased by 11% year-over-year in Q3 2025, with projections suggesting a nearly 19.5% decline in 2025 due to lower practice salaries and benefits [5] Strategic Initiatives - The company is expanding its telehealth services to enhance healthcare access and improve patient outcomes [6] - MD is actively pursuing mergers and acquisitions in core service lines, having acquired several practices for $19.2 million in September 2025 [7] Cash Flow and Share Repurchase - Net cash generated from operations in Q3 2025 was $138.1 million, an increase from $95.7 million a year ago [8] - In August 2025, MD authorized a $250 million share repurchase program and repurchased $20.9 million worth of shares in Q3 2025 [8] Debt Situation - As of September 30, 2025, MD had a net debt of $602.5 million, significantly higher than its cash balance of $340.1 million, which may pressure interest expenses [11] - The total debt-to-EBITDA ratio stands at 8.1%, well above the industry average of 2.4%, limiting financial flexibility [11]

Core Points - Midland Exploration Inc. has completed a non-brokered private placement, issuing a total of 4,972,876 flow-through shares at $0.56 each and 550,000 common shares at $0.46 each, raising total gross proceeds of $3,037,811 [1][2] - Centerra Gold Inc. has exercised its right to maintain approximately 9.9% ownership by acquiring 550,000 shares as part of the private placement [2] - Insiders participated in the private placement, acquiring 443,500 flow-through shares for total gross proceeds of $348,360, which is classified as a related party transaction [3] - Following the private placement, Midland has 112,973,453 common shares issued and outstanding, and the transaction is subject to final acceptance by the TSX Venture Exchange [4] Financial Details - The total gross proceeds from the private placement amount to $3,037,811, with $348,360 raised from insider participation [1][3] - Finder's fees totaling $116,485 were paid to third parties in connection with the private placement [4] Company Strategy - Midland plans to use the proceeds from the private placement to fund exploration activities on its properties in Quebec and for general corporate purposes [2] - The company is focused on discovering new world-class deposits of gold and critical metals in Quebec and aims to build its portfolio through partnerships and additional agreements [5]

Core Insights - Midland Exploration Inc. and SOQUEM Inc. announced positive results from the 2025 exploration campaign on the Nachicapau project, highlighting the discovery of a major hydrothermal system with high-grade copper, gold, and silver [3][4][19] Exploration Results - The 2025 sampling campaign lasted 9 days in September, collecting 213 rock samples, with 23 samples showing grades greater than 0.10% Cu, including 11 samples exceeding 1.00% Cu, with the highest at 13.70% Cu [5][7] - Significant gold grades were also identified, with values reaching up to 4.83 g/t Au, and silver grades up to 65.40 g/t Ag [5][7] - Six new mineralized showings were discovered, with notable grades including 4.66% Cu, 0.20 g/t Au, and 13.8 g/t Ag associated with disseminated chalcopyrite mineralization [7][13] Geological Context - The new mineralized showings are associated with veins hosting digenite, bornite, and malachite, with four showings exhibiting gold contents above 1.00 g/t Au, indicating a favorable metallotect for future exploration [12] - The spatial distribution of these showings spans nearly 2.7 km along the contact between mafic rocks and dolomites, suggesting significant exploration potential [12] Induced Polarization Survey - An OreVision® induced polarization survey was conducted over 20.45 km, revealing several anomalies that are currently under analysis to determine the best drill-testing strategy for future exploration phases [15][16] Strategic Alliance - The Strategic Alliance between Midland and SOQUEM aims to explore the mineral potential of the Labrador Trough, with a commitment of up to $5 million over four years, including a $1 million annual budget for 2025 [19][20]

Core Viewpoint - Pediatrix Medical Group (MD) has shown strong stock performance, with a 36.6% increase over the past month and an 81.6% gain since the start of the year, outperforming the Zacks Medical sector and Zacks Medical Services industry [1][2]. Financial Performance - The company has consistently exceeded earnings expectations, reporting an EPS of $0.67 against a consensus estimate of $0.46 in its last earnings report [2]. - For the current fiscal year, Pediatrix Medical Group is projected to achieve earnings of $2.06 per share on revenues of $1.91 billion, reflecting a 36.42% increase in EPS but a 5.04% decrease in revenues [3]. - The next fiscal year is expected to see earnings of $2.08 per share on revenues of $1.98 billion, indicating a year-over-year change of 0.68% in EPS and 3.33% in revenues [3]. Valuation Metrics - The stock trades at 11.6 times the current fiscal year EPS estimates, below the peer industry average of 16 times [7]. - On a trailing cash flow basis, it trades at 13.5 times compared to the peer group's average of 10.1 times, suggesting it is not among the top value stocks [7]. Zacks Rank and Style Scores - Pediatrix Medical Group holds a Zacks Rank of 1 (Strong Buy) due to a favorable earnings estimate revision trend [8]. - The company has a Value Score of B, a Growth Score of B, and a Momentum Score of A, resulting in a combined VGM Score of A [6][9]. Competitive Landscape - In comparison to industry peers, Progyny, Inc. (PGNY) also shows strong performance with a Zacks Rank of 2 (Buy) and similar style scores [10]. - PGNY is expected to post earnings of $1.93 per share on revenues of $1.27 billion for the current fiscal year, having beaten consensus estimates by 15.38% last quarter [11].

Core Viewpoint - Pediatrix Medical Group, Inc. (NYSE:MD) is identified as a promising small-cap stock, with a price target increase from $17 to $24 by Truist Financial, maintaining a Buy rating [1]. Financial Performance - The company experienced a 33.59% increase in share price following the release of its fiscal Q3 2025 results, which showed quarterly revenue of $492.88 million, a decrease of 3.58% year-over-year, but exceeding analysts' estimates by $16.43 million [2]. - Earnings per share (EPS) for the quarter was $0.67, surpassing consensus estimates by $0.20 [2]. Revenue Analysis - The revenue decline was attributed to a portfolio restructuring activity costing approximately $54 million. However, this was mitigated by an 8% growth in same-unit performance, a 7.5% increase in same-unit pricing, and a 40 basis points rise in patient service volumes [3]. EBITDA and Guidance - Adjusted EBITDA for the quarter reached $87 million, exceeding management's expectations, driven by positive pricing outcomes, collections, and expense controls [4]. - The company raised its full-year adjusted EBITDA guidance to a range of $270 million to $290 million, up from the previous range of $245 million to $255 million [4]. Company Overview - Pediatrix Medical Group, Inc. is a leading provider of specialized physician services for women, babies, and children, focusing on newborn, maternal-fetal, and pediatric subspecialty care [5].

Core Viewpoint - Midland Exploration Inc. has signed a definitive option agreement with Barrick Mining Corporation for the Lewis gold property, allowing Barrick to acquire up to a 75% interest in the property through cash payments and exploration work [1][2]. Option Agreement Details - Barrick can acquire a 75% interest in the Lewis property by making total cash payments of $750,000 and funding exploration work of $12,000,000 by December 31, 2032 [2]. - An initial 51% interest can be earned by Barrick through a cash payment of $250,000 and funding at least $3,000,000 in exploration work, including a guaranteed $200,000 by December 31, 2028, leading to a joint venture [3]. - An additional 9% interest can be earned by making cash payments of $200,000 and funding at least $1,500,000 in exploration work by December 31, 2030 [4]. - A further 15% interest can be earned by making cash payments of $300,000 and funding at least $7,500,000 in exploration work by December 31, 2032 [4]. Joint Venture and Ownership Adjustments - If Barrick does not complete the funding options, the joint venture interests will be subject to adjustments based on funding and dilution terms, with dilution below 10% converting to a 2% net smelter return royalty [5]. About the Lewis Property - The Lewis property consists of 154 exclusive exploration rights covering 86 km and is strategically located near significant geological features, including the Nelligan deposit, which has inferred resources of 106.395 million tonnes grading 0.96 g/t Au [6]. - The property is also near the former Lac Shortt mine, which historically produced 2.7 million tonnes at a grade of 4.6 g/t Au [6]. Company Overview - Midland targets mineral potential in Quebec, aiming to discover new world-class deposits of gold and critical metals, and collaborates with reputable partners including Barrick and others [7].